Cathie Wood Arcturus Therapeutics Holdings Inc. Transaction History

Ark Investment Management LLC

$12.1 Billion
Q2 2025

A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 1,715,040 shares of ARCT stock, worth $25.5 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

1,715,040

Previous 2,008,480 14.61%

Holding current value

$25.5 Million

Previous $21.3 Million 4.9%

% of portfolio

0.18%

Previous 0.23%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	SELL	$8.91 - $14.41 $2.61 Million - $4.23 Million	-293,440 Reduced 14.61%	1,715,040 $22.3 Million
Q1 2025 May 07, 2025	BUY	$10.59 - $20.83 $790,321 - $1.55 Million	74,629 Added 3.86%	2,008,480 $21.3 Million
Q4 2024 Feb 04, 2025	SELL	$14.82 - $25.48 $2.48 Million - $4.26 Million	-167,187 Reduced 7.96%	1,933,851 $32.8 Million
Q3 2024 Oct 31, 2024	BUY	$18.08 - $25.38 $2.46 Million - $3.45 Million	136,074 Added 6.93%	2,101,038 $48.8 Million
Q2 2024 Jul 26, 2024	BUY	$24.35 - $44.39 $6.7 Million - $12.2 Million	275,315 Added 16.29%	1,964,964 $47.8 Million
Q1 2024 Apr 18, 2024	SELL	$31.23 - $42.99 $11.2 Million - $15.4 Million	-358,038 Reduced 17.48%	1,689,649 $57.1 Million
Q4 2023 Jan 17, 2024	BUY	$17.71 - $32.97 $2.59 Million - $4.82 Million	146,141 Added 7.69%	2,047,687 $64.6 Million
Q3 2023 Oct 18, 2023	SELL	$25.44 - $37.35 $138,648 - $203,557	-5,450 Reduced 0.29%	1,901,546 $48.6 Million
Q2 2023 Jul 10, 2023	SELL	$23.94 - $32.36 $1.88 Million - $2.54 Million	-78,425 Reduced 3.95%	1,906,996 $54.7 Million
Q1 2023 Apr 17, 2023	SELL	$14.72 - $23.97 $397,557 - $647,381	-27,008 Reduced 1.34%	1,985,421 $47.6 Million
Q4 2022 Jan 24, 2023	SELL	$14.14 - $23.06 $2.39 Million - $3.9 Million	-169,274 Reduced 7.76%	2,012,429 $0
Q3 2022 Oct 17, 2022	SELL	$13.05 - $22.13 $1.59 Million - $2.7 Million	-122,048 Reduced 5.3%	2,181,703 $32.3 Million
Q2 2022 Jul 11, 2022	SELL	$12.26 - $31.17 $981,891 - $2.5 Million	-80,089 Reduced 3.36%	2,303,751 $45.8 Million
Q1 2022 Apr 19, 2022	SELL	$17.64 - $39.57 $1.57 Million - $3.51 Million	-88,790 Reduced 3.59%	2,383,840 $64.3 Million
Q4 2021 Jan 28, 2022	SELL	$34.2 - $47.56 $1.95 Million - $2.71 Million	-56,879 Reduced 2.25%	2,472,630 $91.5 Million
Q3 2021 Nov 12, 2021	SELL	$27.88 - $58.25 $9.9 Million - $20.7 Million	-355,173 Reduced 12.31%	2,529,509 $121 Million
Q2 2021 Aug 05, 2021	SELL	$25.79 - $42.11 $11.5 Million - $18.8 Million	-447,207 Reduced 13.42%	2,884,682 $97.6 Million
Q1 2021 May 13, 2021	SELL	$38.75 - $86.92 $24.3 Million - $54.5 Million	-627,130 Reduced 15.84%	3,331,889 $138 Million
Q4 2020 Feb 12, 2021	BUY	$34.61 - $123.66 $50.6 Million - $181 Million	1,463,177 Added 58.62%	3,959,019 $172 Million
Q3 2020 Oct 30, 2020	BUY	$37.49 - $63.19 $21.6 Million - $36.5 Million	577,007 Added 30.07%	2,495,842 $107 Million
Q2 2020 Aug 11, 2020	BUY	$12.66 - $58.27 $4.49 Million - $20.6 Million	354,378 Added 22.65%	1,918,835 $89.7 Million
Q1 2020 May 14, 2020	BUY	$9.31 - $18.26 $1.68 Million - $3.3 Million	180,701 Added 13.06%	1,564,457 $21.3 Million
Q4 2019 Jan 31, 2020	BUY	$8.93 - $12.41 $976,432 - $1.36 Million	109,343 Added 8.58%	1,383,756 $15 Million
Q3 2019 Nov 12, 2019	BUY	$8.8 - $14.5 $2.38 Million - $3.92 Million	270,045 Added 26.89%	1,274,413 $13.1 Million
Q2 2019 Jul 30, 2019	BUY	$5.78 - $9.79 $5.81 Million - $9.83 Million	1,004,368 New	1,004,368 $9.48 Million

Others Institutions Holding ARCT

# of Institutions

170

Shares Held

25.9M

Call Options Held

321K

Put Options Held

120K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $396M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track Cathie Wood's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Account